A New Frontier in the Fight Against Cancer (That Is, for Those Who Can Afford It)
The Food and Drug Administration (FDA) made history this fall with its approval of Novartis’s Kymirah and Gilead’s Yescarta—the first gene therapies to ever be approved in the United States. [1,2] Both treatments belong to a new class of cancer therapeutics called CAR T-cell treatments, which use pa...
Αποθηκεύτηκε σε:
| Κύριος συγγραφέας: | |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Columbia University Libraries
2018-01-01
|
| Σειρά: | Voices in Bioethics |
| Θέματα: | |
| Διαθέσιμο Online: | https://journals.library.columbia.edu/index.php/bioethics/article/view/6024 |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|